These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32830366)

  • 41. Cognitive impairment in a 65-year-old male with the fragile X-associated tremor-ataxia syndrome (FXTAS).
    Grigsby J; Leehey MA; Jacquemont S; Brunberg JA; Hagerman RJ; Wilson R; Epstein JH; Greco CM; Tassone F; Hagerman PJ
    Cogn Behav Neurol; 2006 Sep; 19(3):165-71. PubMed ID: 16957495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers.
    Greco CM; Hagerman RJ; Tassone F; Chudley AE; Del Bigio MR; Jacquemont S; Leehey M; Hagerman PJ
    Brain; 2002 Aug; 125(Pt 8):1760-71. PubMed ID: 12135967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. White matter disease and cognitive impairment in FMR1 premutation carriers.
    Filley CM; Brown MS; Onderko K; Ray M; Bennett RE; Berry-Kravis E; Grigsby J
    Neurology; 2015 May; 84(21):2146-52. PubMed ID: 25925982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fragile X-associated tremor/ataxia syndrome and movements disorders.
    Baba Y; Uitti RJ
    Curr Opin Neurol; 2005 Aug; 18(4):393-8. PubMed ID: 16003114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular and imaging correlates of the fragile X-associated tremor/ataxia syndrome.
    Cohen S; Masyn K; Adams J; Hessl D; Rivera S; Tassone F; Brunberg J; DeCarli C; Zhang L; Cogswell J; Loesch D; Leehey M; Grigsby J; Hagerman PJ; Hagerman R
    Neurology; 2006 Oct; 67(8):1426-31. PubMed ID: 17060569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abnormal trajectories in cerebellum and brainstem volumes in carriers of the fragile X premutation.
    Wang JY; Hessl D; Hagerman RJ; Simon TJ; Tassone F; Ferrer E; Rivera SM
    Neurobiol Aging; 2017 Jul; 55():11-19. PubMed ID: 28391068
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A cerebellar tremor/ataxia syndrome among fragile X premutation carriers.
    Hagerman PJ; Greco CM; Hagerman RJ
    Cytogenet Genome Res; 2003; 100(1-4):206-12. PubMed ID: 14526182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fragile X-associated tremor ataxia syndrome with co-occurrent progressive supranuclear palsy-like neuropathology.
    Sacino AN; Prokop S; Walsh MA; Adamson J; Subramony SH; Krans A; Todd PK; Giasson BI; Yachnis AT
    Acta Neuropathol Commun; 2019 Oct; 7(1):158. PubMed ID: 31665069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abnormal N400 word repetition effects in fragile X-associated tremor/ataxia syndrome.
    Olichney JM; Chan S; Wong LM; Schneider A; Seritan A; Niese A; Yang JC; Laird K; Teichholtz S; Khan S; Tassone F; Hagerman R
    Brain; 2010 May; 133(Pt 5):1438-50. PubMed ID: 20410144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.
    Jacquemont S; Hagerman RJ; Leehey MA; Hall DA; Levine RA; Brunberg JA; Zhang L; Jardini T; Gane LW; Harris SW; Herman K; Grigsby J; Greco CM; Berry-Kravis E; Tassone F; Hagerman PJ
    JAMA; 2004 Jan; 291(4):460-9. PubMed ID: 14747503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential pathogenic mechanisms underlying Fragile X Tremor Ataxia Syndrome: RAN translation and/or RNA gain-of-function?
    Boivin M; Willemsen R; Hukema RK; Sellier C
    Eur J Med Genet; 2018 Nov; 61(11):674-679. PubMed ID: 29223504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methadone use in a male with the FMRI premutation and FXTAS.
    Muzar Z; Lozano R; Schneider A; Adams PE; Faradz SM; Tassone F; Hagerman RJ
    Am J Med Genet A; 2015 Jun; 167(6):1354-9. PubMed ID: 25900641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exploration of SUMO2/3 Expression Levels and Autophagy Process in Fragile X-Associated Tremor/Ataxia Syndrome: Addressing Study Limitations and Insights for Future Research.
    Alvarez-Mora MI; Garrabou G; Molina-Porcel L; Grillo-Risco R; Garcia-Garcia F; Barcos T; Cantó-Santos J; Rodriguez-Revenga L
    Cells; 2023 Sep; 12(19):. PubMed ID: 37830578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FMRpolyG alters mitochondrial transcripts level and respiratory chain complex assembly in Fragile X associated tremor/ataxia syndrome [FXTAS].
    Gohel D; Sripada L; Prajapati P; Singh K; Roy M; Kotadia D; Tassone F; Charlet-Berguerand N; Singh R
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1379-1388. PubMed ID: 30771487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of FXTAS presenting with SCA 12 like phenotype in India.
    Faruq M; Srivastava AK; Suroliya V; Kumar D; Garg A; Shukla G; Behari M
    Parkinsonism Relat Disord; 2014 Oct; 20(10):1089-93. PubMed ID: 25085749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High functioning male with fragile X syndrome and fragile X-associated tremor/ataxia syndrome.
    Basuta K; Schneider A; Gane L; Polussa J; Woodruff B; Pretto D; Hagerman R; Tassone F
    Am J Med Genet A; 2015 Sep; 167A(9):2154-61. PubMed ID: 25920745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Age- and CGG repeat-related slowing of manual movement in fragile X carriers: A prodrome of fragile X-associated tremor ataxia syndrome?
    Shickman R; Famula J; Tassone F; Leehey M; Ferrer E; Rivera SM; Hessl D
    Mov Disord; 2018 Apr; 33(4):628-636. PubMed ID: 29389022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS).
    Van Dam D; Errijgers V; Kooy RF; Willemsen R; Mientjes E; Oostra BA; De Deyn PP
    Behav Brain Res; 2005 Jul; 162(2):233-9. PubMed ID: 15876460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropathology of
    Dijkstra AA; Haify SN; Verwey NA; Prins ND; van der Toorn EC; Rozemuller AJM; Bugiani M; den Dunnen WFA; Todd PK; Charlet-Berguerand N; Willemsen R; Hukema RK; Hoozemans JJM
    Brain Commun; 2021; 3(1):fcab007. PubMed ID: 33709078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency.
    Buijsen RA; Visser JA; Kramer P; Severijnen EA; Gearing M; Charlet-Berguerand N; Sherman SL; Berman RF; Willemsen R; Hukema RK
    Hum Reprod; 2016 Jan; 31(1):158-68. PubMed ID: 26537920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.